|
See related Coversyl Arginine film-coated tab information |
|
|
|
Manufacturer |
Servier |
|
Distributor |
Zuellig |
|
Contents |
Perindopril arginine |
|
Indications |
Listed in Dosage.
Click to view Coversyl Arginine detailed prescribing infomation |
|
Dosage |
Adult Arterial HTN 5 mg/day in the morning. May be increased to 10 mg/day in a single dose after 1 mth of treatment. Elderly Initially 2.5 mg/day. May be increased to 5 mg/day after 1 mth of treatment. CHF Initially 2.5 mg/day in the morning up to 5 mg/day. Prevention of stroke recurrence in patients w/ a history of cerebrovascular disease 2.5 mg/day for 2 wk, then increase to 5 mg/day for a further 2 wk before introducing indapamide. Reduction of risk of CV event in patients w/ stable coronary artery disease 5 mg once daily for 2 wk up to 10 mg once daily. Elderly 2.5 mg once daily for 1 wk then 5 mg once daily the next wk before increasing to 10 mg once daily.
Click to view Coversyl Arginine detailed prescribing infomation |
|
Overdosage |
View Coversyl Arginine overdosage for action to be taken in the event of an overdose. |
|
Administration |
Should be taken on an empty stomach (Take before meals.). |
|
Contraindications |
Pregnancy, childn <15 yr.
Click to view Coversyl Arginine detailed prescribing infomation |
|
Warnings |
For additional cautionary notes to warn of the potential risk of using the medicine... click to view Coversyl Arginine detailed prescribing infomation |
|
Special Precautions |
Risk of angioneurotic oedema. Dry cough, patients undergoing hemodialysis, congenital galactosemia, renal or heart failure, diabetes, atherosclerosis, renal artery stenosis, hypotension, strict Na-free diet, surgery/anesth. May impair ability to drive or operate machinery.
Click to view Coversyl Arginine detailed prescribing infomation |
|
Adverse Drug Reactions |
Headaches, fatigue, dizziness, mood &/or sleep disturbances, GI pain, taste disturbances, dry cough, slight decrease in Hb, slight increase in blood K levels, increase in blood urea & creatinine.
View ADR Monitoring Form |
|
Drug Interactions |
Lithium, K-sparing diuretics, K salts, estramustine.
View more drug interactions with Coversyl Arginine |
|
Pregnancy Category (US FDA) |
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). |
|
Caution For Usage |
For caution against possible variation of physical aspect of medicine... click to view Coversyl Arginine detailed prescribing infomation |
|
Storage |
View Coversyl Arginine storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Coversyl Arginine description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Coversyl Arginine mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
